ACAD
36.045
0.00
0.00%
AEMD
0.196
-0.01
-4.6341%
APRI
1.62
0.00
0.00%
ARNA
4.22
0.00
0.00%
ATEC
1.41
0.00
0.00%
CNAT
6.35
0.00
0.00%
CRXM
0.415
+0.061
+17.397%
CYTX
0.915
0.00
0.00%
DXCM
67.56
0.00
0.00%
GNMK
10.35
0.00
0.00%
HALO
15.78
0.00
0.00%
ILMN
183.71
0.00
0.00%
INNV
0.145
0.00
0.00%
INO
9.75
-0.31
-3.03%
ISCO
0.074
-0.001
-0.6757%
ISIS
62.72
+0.7
+1.13%
LGND
87.3
0.00
0.00%
LPTN
2.23
0.00
0.00%
MBVX
3.17
-0.19
-5.65%
MEIP
2.07
0.00
0.00%
MNOV
3.76
0.00
0.00%
MRTX
26.98
0.00
0.00%
MSTX
0.476
0.00
0.00%
NBIX
40.11
+0.61
+1.54%
NUVA
43.36
0.00
0.00%
ONCS
0.291
+0.023
+8.582%
ONVO
4.76
-0.11
-2.26%
OREX
6.95
0.00
0.00%
OTIC
28.58
0.00
0.00%
QDEL
23.41
0.00
0.00%
RCPT
160.95
+4.73
+3.0277%
RGLS
14.59
0.00
0.00%
RMD
64.55
0.00
0.00%
SCIE
0.019
-0.007
-27.95367%
SPHS
0.75
0.00
0.00%
SRNE
8.72
-0.64
-6.84%
TROV
8.27
0.00
0.00%
VICL
0.96
0.00
0.00%
VOLC
17.99
0.00
0.00%
ZGNX
1.41
0.00
0.00%
ACAD
36.045
0.00
0.00%
AEMD
0.196
-0.01
-4.6341%
APRI
1.62
0.00
0.00%
ARNA
4.22
0.00
0.00%
ATEC
1.41
0.00
0.00%
CNAT
6.35
0.00
0.00%
CRXM
0.415
+0.061
+17.397%
CYTX
0.915
0.00
0.00%
DXCM
67.56
0.00
0.00%
GNMK
10.35
0.00
0.00%
HALO
15.78
0.00
0.00%
ILMN
183.71
0.00
0.00%
INNV
0.145
0.00
0.00%
INO
9.75
-0.31
-3.03%
ISCO
0.074
-0.001
-0.6757%
ISIS
62.72
+0.7
+1.13%
LGND
87.3
0.00
0.00%
LPTN
2.23
0.00
0.00%
MBVX
3.17
-0.19
-5.65%
MEIP
2.07
0.00
0.00%
MNOV
3.76
0.00
0.00%
MRTX
26.98
0.00
0.00%
MSTX
0.476
0.00
0.00%
NBIX
40.11
+0.61
+1.54%
NUVA
43.36
0.00
0.00%
ONCS
0.291
+0.023
+8.582%
ONVO
4.76
-0.11
-2.26%
OREX
6.95
0.00
0.00%
OTIC
28.58
0.00
0.00%
QDEL
23.41
0.00
0.00%
RCPT
160.95
+4.73
+3.0277%
RGLS
14.59
0.00
0.00%
RMD
64.55
0.00
0.00%
SCIE
0.019
-0.007
-27.95367%
SPHS
0.75
0.00
0.00%
SRNE
8.72
-0.64
-6.84%
TROV
8.27
0.00
0.00%
VICL
0.96
0.00
0.00%
VOLC
17.99
0.00
0.00%
ZGNX
1.41
0.00
0.00%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.